PSAs about OTCs
This article was originally published in The Tan Sheet
Executive SummaryAcetaminophen "is safe and effective when used correctly, but taking too much can lead to liver damage," an internet public service announcement posted to FDA's Consumer Education website states. "Don't take more than one acetaminophen product a day without first speaking to a health care professional," FDA adds. The PSA can be used on websites and linked to consumer education web pages, the agency says. In a separate PSA also announced by the agency, FDA states that "all over-the-counter medicines have one thing in common: Simplicity." The PSA adds: "the easy-to-read format of the Drug Facts label helps consumers choose the over-the-counter medicine that's right for them" and directs readers to the CDER website and a toll-free FDA telephone number...
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.